Personalized Medicine Certification: Immunology, Toxicology and Oncology

The program features an in-depth examination of immunology, toxicology, and oncology as they relate to chronic disease pathophysiology and clinical management. Through a comprehensive review of current research, mechanistic science, and translational applications, participants will develop an integrated understanding of immune dysregulation, environmental exposures, carcinogenesis, and targeted therapeutic strategies.

Target Audience

This conference is designed for an audience of Physicians, Pharmacists, Pharmacy technicians and other healthcare professionals involved with Immunology, Toxicology and Oncology.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

• Evaluate the effectiveness of new therapies designed for toxin removal.

• Assess current methodologies used to measure immune system function

• Explain the evolving relationship between immunology and oncology.

Commercial Support
There is no commercial support for this activity.

Course summary

Available credit:

24.00 ACPE Pharmacist
24.00 ACPE Pharmacy Technician
24.00 AMA PRA Category 1 Credit™
24.00 Attendance

Course opens:

03/18/2026

Course expires:

12/31/2026

Cost:

$0.00

Rating:

March 20-22, 2026 Live in Huntsville, AL

United States

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

All of the relevant financial relationships listed for these individuals have been mitigated.

Reviewer(s)